| scholarly article | Q13442814 |
| P50 | author | Michael S. Diamond | Q28051146 |
| P2093 | author name string | Erin E McCandless | |
| Robyn S Klein | |||
| Elizabeth Sitati | |||
| P2860 | cites work | Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay | Q24575556 |
| Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation | Q24677534 | ||
| CCR5 deficiency increases risk of symptomatic West Nile virus infection | Q24677652 | ||
| Complement activation is required for induction of a protective antibody response against West Nile virus infection | Q27469834 | ||
| Protective Mechanisms Induced by a Japanese Encephalitis Virus DNA Vaccine: Requirement for Antibody but Not CD8+ Cytotoxic T-Cell Responses | Q27469884 | ||
| Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis | Q27470828 | ||
| Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival | Q27472671 | ||
| CD8+ T Cells Require Perforin To Clear West Nile Virus from Infected Neurons | Q27472780 | ||
| B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. | Q27473103 | ||
| Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus | Q27473186 | ||
| Gamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus Infection | Q27473224 | ||
| Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion | Q27477543 | ||
| CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System | Q27477717 | ||
| Protective immune responses against West Nile virus are primed by distinct complement activation pathways | Q27482651 | ||
| A Critical Role for Induced IgM in the Protection against West Nile Virus Infection | Q27485124 | ||
| Activation of Virus-specific Memory B Cells in the Absence of T Cell Help | Q27485181 | ||
| Partial Genetic Characterization of West Nile Virus Strains, New York State, 2000 | Q27487791 | ||
| CD40-CD40 ligand | Q28143324 | ||
| The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation | Q28586300 | ||
| Role of CD8+ T cells in control of West Nile virus infection | Q29619668 | ||
| CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection | Q33783902 | ||
| Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40. | Q33834753 | ||
| Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis | Q33835268 | ||
| Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome | Q33849472 | ||
| CD40 is expressed and functional on neuronal cells | Q34085854 | ||
| CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis | Q34226788 | ||
| CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. | Q34339494 | ||
| Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand | Q34367466 | ||
| Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases | Q35022580 | ||
| Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection. | Q35797635 | ||
| CD40: a growing cytoplasmic tale | Q35806202 | ||
| CD40 ligand: a novel target in the fight against cardiovascular disease | Q35848866 | ||
| CD40 ligand-deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to a viral infection | Q35873254 | ||
| West Nile virus: where are we now? | Q35874060 | ||
| The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms | Q36205278 | ||
| The expression and function of chemokines involved in CNS inflammation | Q36323788 | ||
| Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals | Q36365548 | ||
| CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions | Q36366592 | ||
| The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. | Q36369234 | ||
| CD40-deficient, influenza-specific CD8 memory T cells develop and function normally in a CD40-sufficient environment | Q36371544 | ||
| CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes | Q36375919 | ||
| Activating anti-CD40 antibodies induce tumour invasion by cytotoxic T-lymphocytes and inhibition of tumour growth in experimental liver cancer | Q40299997 | ||
| Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice | Q40344535 | ||
| The Role of CD40 and its Ligand in the Regulation of the Immune Response | Q40391931 | ||
| RNAi-mediated silencing of CD40 prevents leukocyte adhesion on CD154-activated endothelial cells. | Q40488849 | ||
| IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection | Q40551940 | ||
| CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction | Q40587639 | ||
| Immunity to rotavirus in T cell deficient mice. | Q41076599 | ||
| CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. | Q41898717 | ||
| Immunobiology of mosquito-borne encephalitic flaviviruses | Q42982030 | ||
| CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. | Q45420445 | ||
| Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection | Q45420662 | ||
| Measles virus infection induces chemokine synthesis by neurons | Q45721917 | ||
| Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. | Q46007698 | ||
| CD40-CD40L interactions promote neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism | Q46483832 | ||
| CD40L deletion delays neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism | Q46499277 | ||
| CD40 signaling in vascular cells: a key role in atherosclerosis? | Q47726341 | ||
| T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions | Q47982736 | ||
| Help for cytotoxic-T-cell responses is mediated by CD40 signalling | Q47982749 | ||
| A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell | Q47982760 | ||
| Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells | Q47992054 | ||
| Induction of beta-chemokine secretion by human brain microvessel endothelial cells via CD40/CD40L interactions. | Q48104241 | ||
| Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis | Q48160439 | ||
| CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis | Q48365016 | ||
| CD40 expressed by human brain endothelial cells regulates CD4+ T cell adhesion to endothelium | Q48415768 | ||
| Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. | Q48537815 | ||
| Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis | Q48913563 | ||
| CD40-mediated activation of T cells accelerates, but is not required for, encephalitogenic potential of myelin basic protein-recognizing T cells in a model of progressive experimental autoimmune encephalomyelitis | Q49025682 | ||
| The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. | Q51639878 | ||
| Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key. | Q52002766 | ||
| Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. | Q52023146 | ||
| Determination of total and merecaptothanol-resistant antibody in the same serum sample. | Q54681669 | ||
| Functional defects of dendritic cells in patients with CD40 deficiency | Q57394761 | ||
| West Nile virus | Q64127859 | ||
| CD154 (CD40L) induces human endothelial cell chemokine production and migration of leukocyte subsets | Q73386215 | ||
| A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory | Q74813297 | ||
| T-cell-independent antiviral antibody responses | Q77174567 | ||
| CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection | Q81375555 | ||
| CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation | Q82310803 | ||
| P433 | issue | 18 | |
| P921 | main subject | West Nile virus | Q158856 |
| encephalitis | Q199615 | ||
| P304 | page(s) | 9801-11 | |
| P577 | publication date | 2007-09-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis | |
| P478 | volume | 81 |
| Q40073958 | A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses |
| Q36001196 | Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation |
| Q89794663 | Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection |
| Q93052209 | B Cell and CD4 T Cell Interactions Promote Development of Atherosclerosis |
| Q37673123 | B cell response and mechanisms of antibody protection to West Nile virus |
| Q37308134 | CD154 deficiency uncouples allograft CD8+ T-cell effector function from proliferation and inhibits murine airway obliteration |
| Q36667984 | CD22 is required for protection against West Nile virus Infection |
| Q34980404 | CD8+ T cells complement antibodies in protecting against yellow fever virus |
| Q37411386 | CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease? |
| Q27489646 | Cellular Inflammatory Response to Flaviviruses in the Central Nervous System of a Primate Host |
| Q36112729 | Chemokines Referee Inflammation within the Central Nervous System during Infection and Disease |
| Q33517926 | Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies |
| Q36177011 | Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection |
| Q37376398 | Differential virulence and pathogenesis of West Nile viruses |
| Q34015684 | Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis |
| Q27487142 | Early B-Cell Activation after West Nile Virus Infection Requires Alpha/Beta Interferon but Not Antigen Receptor Signaling |
| Q34438501 | Effect of serum heat-inactivation and dilution on detection of anti-WNV antibodies in mice by West Nile virus E-protein microsphere immunoassay |
| Q38216286 | Flaviviruses are neurotropic, but how do they invade the CNS? |
| Q42585205 | Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD). |
| Q41480082 | IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis |
| Q34406318 | IL-22 signaling contributes to West Nile encephalitis pathogenesis |
| Q38068093 | Immune responses to West Nile virus infection in the central nervous system |
| Q38168950 | Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: from bedside to bench and back again |
| Q36457613 | Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors |
| Q35851023 | MHC class Ib-restricted CD8 T cells differ in dependence on CD4 T cell help and CD28 costimulation over the course of mouse polyomavirus infection |
| Q38150821 | Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators |
| Q37592281 | Pathogen translocation across the blood-brain barrier |
| Q59352035 | Peli1 facilitates virus replication and promotes neuroinflammation during West Nile virus infection |
| Q36362733 | Phenotypic characterisation of cell populations in the brains of horses experimentally infected with West Nile virus. |
| Q33430173 | SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation |
| Q34020909 | TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis |
| Q34937936 | TNF-α acts as an immunoregulator in the mouse brain by reducing the incidence of severe disease following Japanese encephalitis virus infection |
| Q27489537 | The Immune Adaptor Molecule SARM Modulates Tumor Necrosis Factor Alpha Production and Microglia Activation in the Brainstem and Restricts West Nile Virus Pathogenesis |
| Q40347486 | The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system |
| Q38120697 | The neuroimmune response to West Nile virus |
| Q27487955 | The structural immunology of antibody protection against West Nile virus |
| Q27487124 | Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection |
| Q27488876 | Toll-like Receptor 7 Mitigates Lethal West Nile Encephalitis via Interleukin 23-Dependent Immune Cell Infiltration and Homing |
| Q37006727 | Toll-like receptor 7 suppresses virus replication in neurons but does not affect viral pathogenesis in a mouse model of Langat virus infection |
| Q27486917 | Tumor Necrosis Factor Alpha Protects against Lethal West Nile Virus Infection by Promoting Trafficking of Mononuclear Leukocytes into the Central Nervous System |
| Q37727208 | Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity |
| Q26766121 | West Nile Virus Infection in the Central Nervous System |
| Q26865618 | West Nile Virus: biology, transmission, and human infection |
| Q27488411 | West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier |
| Q36418554 | West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection |
| Q37876095 | West Nile virus: the complex biology of an emerging pathogen |
| Q30227143 | West nile virus: characteristics of an african virus adapting to the third millennium world. |
Search more.